COSCIENS Biopharma Inc. Reports Q2 2026 Results

TORONTO, ONTARIO, Aug. 11, 2026 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCI.F) (“COSCIENS” or the “Company”) today reported its financial and operating results for the second quarter ended June 30, 2026. All amounts in this press release are in U.S. dollars. Q2 2026 and YTD Financial Highlights $5.3 million in cash and […]